Variant report

Variant	nsv981101
Chromosome Location	chr6:5787642-5788880
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-NRN1-6	chr6:5788579-5788932	NONHSAT107524
2	lnc-NRN1-6	chr6:5788579-5788893	NONHSAT107523

Extended variants
information (count: 66 )
Associated
traits (count: 99 )

Variant overlapped rSNPs/rCNVs (count:66 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs370067398	chr6:5787649-5787650	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs60232193	chr6:5787660-5787661	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs60475061	chr6:5787678-5787679	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs548599470	chr6:5787701-5787702	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs550369871	chr6:5787704-5787705	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs571845158	chr6:5787730-5787731	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs568611988	chr6:5787738-5787739	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs55991338	chr6:5787774-5787775	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs566520058	chr6:5787782-5787783	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs55864325	chr6:5787787-5787788	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs555020803	chr6:5787805-5787806	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs111775852	chr6:5787814-5787815	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs115985836	chr6:5787843-5787844	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs149386175	chr6:5787894-5787895	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs11760165	chr6:5787898-5787899	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs577400766	chr6:5787905-5787906	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs60625891	chr6:5787910-5787911	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs569970549	chr6:5787915-5787916	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs144583014	chr6:5787917-5787918	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs374880721	chr6:5787918-5787919	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs60701843	chr6:5787920-5787921	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs370198219	chr6:5787921-5787922	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs560015199	chr6:5787938-5787939	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs4960135	chr6:5787977-5787978	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs4960136	chr6:5788001-5788002	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
26	rs541097014	chr6:5788002-5788003	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs577551464	chr6:5788005-5788006	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs35165664	chr6:5788009-5788010	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs561095939	chr6:5788010-5788011	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs4960137	chr6:5788014-5788015	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs144666255	chr6:5788019-5788020	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs4960138	chr6:5788022-5788023	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs199505847	chr6:5788084-5788085	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs546664711	chr6:5788086-5788087	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs199687361	chr6:5788098-5788099	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs547964230	chr6:5788111-5788112	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs566385013	chr6:5788136-5788137	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs536509743	chr6:5788167-5788168	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs557020303	chr6:5788248-5788249	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs148500333	chr6:5788313-5788314	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs182116763	chr6:5788320-5788321	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs59386661	chr6:5788345-5788346	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs116148806	chr6:5788383-5788384	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs145362436	chr6:5788394-5788395	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs544810561	chr6:5788396-5788397	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs147839886	chr6:5788409-5788410	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs572029014	chr6:5788420-5788421	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs72821941	chr6:5788485-5788486	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs564455506	chr6:5788496-5788497	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs9504516	chr6:5788525-5788526	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:99)

Disease	PMID	Source
Developmental delay	19490664	CNVD
Cancer	21183584	CNVD
Multiple Epiphyseal Dysplasia	20877625	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Glaucoma	18694899	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Myelodysplastic syndrome	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Bladder cancer	21909424	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
small cell lung cancer	20016488	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
dysmorphism	22105932	CNVD
psychomotor delay	22105932	CNVD
Ovarian cancer	19193619	CNVD
Osteosarcoma	16790693	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21364760	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:29 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:5781600-5788000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
2	chr6:5782200-5788200	Enhancers	Fetal Thymus	thymus
3	chr6:5783800-5794600	Weak transcription	Psoas Muscle	Psoas
4	chr6:5786000-5787800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr6:5786400-5787800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr6:5786600-5787800	Enhancers	Primary T helper naive cells from peripheral blood	blood
7	chr6:5786600-5788000	Enhancers	Primary T cells from cord blood	blood
8	chr6:5786800-5787800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
9	chr6:5786800-5787800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr6:5786800-5788000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
11	chr6:5786800-5788000	Enhancers	Dnd41	blood
12	chr6:5787000-5787800	Enhancers	H1 Cell Line	embryonic stem cell
13	chr6:5787000-5787800	Enhancers	Primary T helper cells PMA-I stimulated	--
14	chr6:5787000-5787800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
15	chr6:5787000-5787800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
16	chr6:5787000-5788000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
17	chr6:5787000-5788000	Enhancers	Primary T cells fromperipheralblood	blood
18	chr6:5787000-5788000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
19	chr6:5787000-5789200	Enhancers	Fetal Muscle Leg	muscle
20	chr6:5787200-5788000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
21	chr6:5787200-5788000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
22	chr6:5787400-5787800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
23	chr6:5787400-5788000	Enhancers	HUES64 Cell Line	embryonic stem cell
24	chr6:5787400-5793000	Weak transcription	Fetal Brain Female	brain
25	chr6:5787600-5787800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
26	chr6:5787600-5787800	Enhancers	Cortex derived primary cultured neurospheres	brain
27	chr6:5787800-5791600	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
28	chr6:5787800-5803800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
29	chr6:5788800-5789000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links